CAS 922174-60-5

L-Lysine, L-α-glutamyl-L-alanyl-L-arginyl-L-prolyl-L-alanyl-L-leucyl-L-leucyl-L-threonyl-L-seryl-L-arginyl-L-leucyl-L-arginyl-L-phenylalanyl-L-isoleucyl-L-prolyl-, hydrochloride (1:1)

Description:

L-Lysine, L-α-glutamyl-L-alanyl-L-arginyl-L-prolyl-L-alanyl-L-leucyl-L-leucyl-L-threonyl-L-seryl-L-arginyl-L-leucyl-L-arginyl-L-phenylalanyl-L-isoleucyl-L-prolyl-, hydrochloride (1:1) is a complex peptide composed of multiple amino acids, primarily featuring lysine and various other L-amino acids in its structure. This compound is characterized by its high solubility in water due to the presence of multiple polar side chains, which enhances its interaction with aqueous environments. As a hydrochloride salt, it is typically more stable and easier to handle than its free base form. The presence of multiple amino acids suggests potential bioactivity, possibly influencing protein synthesis, cellular signaling, or metabolic pathways. This compound may be utilized in research settings, particularly in studies related to peptide synthesis, protein engineering, or as a supplement in nutritional formulations. Its specific properties, such as melting point, stability, and reactivity, would depend on the overall structure and the interactions between the amino acid residues.

Formula: C₈₅H₁₄₆N₂₆O₂₁·ClH

Synonyms:

• Tertomotide hydrochloride

Tertomotide hydrochloride

CAS: 922174-60-5

Tertomotide (GV1001) hydrochloride is a peptide vaccine composed of a 16-amino acid sequence from human telomerase reverse transcriptase (hTERT). It exhibits neuroprotective properties and has potential for research in Alzheimer's disease.

Formula: C₈₅H₁₄₇ClN₂₆O₂₁

Color and Shape: Solid

Molecular weight: 1904.69

Ref: TM-TP3035